Earnings Alerts

Olympus Corp (7733) Earnings: Fiscal Year Forecast Misses Estimates Despite Strong Q4 Performance

  • Olympus expects its full-year operating income to be 150.00 billion yen, which is lower than the estimated 173.04 billion yen.
  • The forecasted net income for the full year is 105.00 billion yen, below the expected 122.42 billion yen.
  • Projected net sales for the full year are 999.00 billion yen, slightly under the anticipated 1.03 trillion yen.
  • Olympus plans to provide a dividend of 30.00 yen, which exceeds the estimated 21.60 yen.
  • Fourth-quarter operating income increased significantly to 53.67 billion yen from 4.56 billion yen year-over-year, surpassing the estimate of 41.85 billion yen.
  • Net income for the fourth quarter rose to 41.47 billion yen compared to 7.35 billion yen year-over-year, exceeding the projected 29.13 billion yen.
  • Net sales for the fourth quarter were 272.11 billion yen, representing a 4.5% year-over-year growth, slightly surpassing the estimate of 270.28 billion yen.
  • The current market sentiment includes 11 buy ratings, 5 hold ratings, and no sell ratings for Olympus.

Olympus Corp on Smartkarma

Analyst coverage of Olympus Corp on Smartkarma provides insights into the company’s recent performance and future prospects. Tina Banerjee‘s research on Olympus Corp (7733 JP) highlights the impacts of foreign exchange fluctuations on the company’s financials. While favorable foreign exchange rates boosted revenue growth in the 9 months of FY25, challenges in the China market and quality-related expenses led to stagnant profits. As a result, Olympus revised its FY25 revenue guidance downward, indicating a cautious outlook for the future.

Further analysis by Tina Banerjee reveals that one-off events contributed to a boost in Olympus’s H1FY25 results. Despite this, the overall sentiment is bearish, with concerns about the company’s FY25 guidance and recent leadership changes. The resignation of the CEO and weak H1FY25 results have contributed to a 17% decline in Olympus Corp shares. The research points to a cautious stance on the company’s future performance, emphasizing the need for careful monitoring of key indicators to gauge Olympus Corp‘s resilience in the face of ongoing challenges.


A look at Olympus Corp Smart Scores

FactorScoreMagnitude
Value2
Dividend2
Growth3
Resilience3
Momentum2
OVERALL SMART SCORE2.4

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Analysts at Smartkarma Smart Scores have assessed Olympus Corp‘s long-term outlook based on key factors. With moderate scores in Value and Dividend at 2, the company shows potential for growth highlighted by a score of 3 in Growth. Furthermore, Olympus Corp demonstrates resilience in its operations with a score of 3 in Resilience, indicating stability in challenging market conditions. However, the company may be lacking in terms of Momentum, with a score of 2, suggesting potential sluggishness in short-term performance.

Olympus Corporation, known for manufacturing optoelectronic products including cameras, endoscopes, microscopes, and office communication systems, is positioned with a steady outlook for the future. While showing areas of strength such as growth potential and operational resilience, investors may need to consider the company’s current momentum when making long-term investment decisions. Overall, Olympus Corp appears well-rounded with opportunities for growth and stability in its sector.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars